DZNep Kolon Kanseri Hücre Hattı HT-29?da Otofaji Gen İfadelerini Etkilememektedir

Year 2019, Volume: 5 Issue: 3, 521 - 525, 01.01.2019

Timur Koca Ersin Akıncı Betül Ünal Cumhur İbrahim Başsorgun Gülsüm Özlem Elpek

Abstract

Amaç: Otofaji AP , fonksiyonel olmayan organelleri ve hatalı katlanmış proteinleri degrade ederek, hücrenin hayatta kalmasını sağlayan iyi korunmuş bir mekanizmadır. 3-Deazaneplanocin A hydrochloride DZNep ve otofaji arasındaki ilişkiyi inceleyen az sayıda çalışma bulunmaktadır. Bu öncül çalışmanın amacı, DZNep'in kolon kanseri hücre hattı HT-29'da otofaji ile ilişkili genler olan, Beclin-1, Ulk1, Ulk2 ve Uvrag'a olan etkilerini araştırmaktır.Gereç ve Yöntemler: HT-29 insan kolorektal adenokarsinom hücreleri kültür ortamına ekildi. Ertesi gün, S-Adenosylmethionine bağımlı metiltransferaz inhibitörü olan 25 µmol DZNep, hücre kültürüne ilave edildi. DZNep, dört gün sonra kültür ortamı değiştirilerek hücrelerden uzaklaştırıldı. Hücreler deney süresince doku kültürü inkübatöründe tutuldu. DZNep uygulamasının 4. gününde, DZNep uygulanmış ve uygulanmamış hücrelerden total RNA izolasyonu yapıldı. cDNA’lar, DNaz uygulanmış 2 µg RNA’dan ters transkriptaz ile sentezlendi. cDNA’lar daha sonra kantitatif polimeraz zincir reaksiyonu ile analiz edildi. Sonuçlar, HT-29 hücrelerinde relatif ekspresyon düzeyleri şeklinde sunuldu.Bulgular: DZNep, HT-29 kolorektal kanser hücrelerinin %50’sinden fazlasını öldürerek ekstrem hücre ölümünü indükledi. Otofaji genlerinin ifadeleri şu şekildeydi; Beclin-1 için hafif, Ulk1 ve Uvrag için orta ve Ulk2 için yüksek.Sonuç: Burada çalışılan bazı otofaji genleri; Beclin-1, Ulk1, Ulk2, Uvrag, DZNep uygulamasından etkilenmemiştir. DZNep uygulaması sonucunda, HT-29 hücrelerinde meydana gelen hücre ölümü otofaji aracılı değildir

Keywords

3-Deazaneplanocin A, Otofaji, HT-29, Kolon karsinomu, Gen ifadesi

DZNep Does Not Influence Autophagy Gene Expression in the Colon Cancer Cell Line HT-29

Abstract

Objective: Autophagy AP is a well-preserved cell survival mechanism that plays a critical role by degrading dysfunctional organelles and misfolded proteins. There are a limited number of studies examining the relationship between 3-Deazaneplanocin A hydrochloride DZNep and autophagy. The purpose of this preliminary study was to assess the effect of DZNep on the expression of the APrelated genes Beclin-1, Ulk1, Ulk2 and Uvrag in HT-29 colorectal adenocarcinoma cells.Material and Methods: HT-29 human colorectal adenocarcinoma cells were plated into growth medium. The next day, 25 µM DZNep, an inhibitor of S-Adenosylmethionine-dependent methyltransferase, was added to the cells. DZNep were removed from the cells after 4 days by refreshing the media. The cells were maintained in a tissue culture incubator. Total RNA isolation was performed from DZNep treated and untreated HT-29 cells 4 days after DZNep application. cDNAs were reverse transcribed from 2 µg of DNase treated RNA. cDNAs were then analyzed by quantitative PCR. The results were presented as relative expression level in HT-29 cells. Results: DZNep induced extreme cell death on HT-29 colorectal cancer cell lines; more than 50% of the colorectal cancer cells were dead. The expression level of Beclin-1 was the smallest while Ulk1 and Uvrag expression levels were higher than that of Beclin-1, and Ulk2 had the highest expression level in untreated HT-29 colorectal cancer lines. Conclusion: The autophagy related genes studied here consisting of Beclin-1, Ulk1, Ulk2, and Uvrag were not affected by DZNep application. Based on mRNA expression levels of AP genes, administration of DZNep does not stimulate cell toxicity through autophagy in the HT-29 cells

Keywords

3-Deazaneplanocin A, Autophagy, HT-29, Colon carcinoma, Gene expression

References

• Bednarczyk M, Zmarzły N, Grabarek B, Mazurek U, Muc-Wierzgoń M. Genes involved in the regulation of different types of autophagy and their participation in cancer pathogenesis. Oncotarget 2018; 9:34413-28.
• Zhan L, Li J, Wei B. Autophagy therapeutics: Preclinical basis and initial clinical studies. Cancer Chemother Pharmacol 2018; 82:923-34.
• Li YJ, Lei YH, Yao N, Wang CR, Hu N, Ye WC, Zhang DM, Chen ZS. Autophagy and multidrug resistance in cancer. Chin J Cancer 2017; 36:52.
• Chen C, Wang K, Wang Q, Wang X. LncRNA HULC mediates radioresistance via autophagy in prostate cancer cells. Braz J Med Biol Res 2018; 51:e7080.
• Taylor MA, Das BC, Ray SK. Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma. Apoptosis 2018; 23:563-75.
• Bishop E, Bradshaw TD. Autophagy modulation: A prudent approach in cancer treatment? Cancer Chemother Pharmacol 2018; 82:913-22.
• Pandurangan AK, Ismail S, Esa NM, Munusamy MA. Inositol-6 phosphate inhibits the mTOR pathway and induces autophagy-mediated death in HT-29 colon cancer cells. Arch Med Sci 2018; 14:1281-8.
• Liu Y, Yang EJ, Zhang B, Miao Z, Wu C, Lyu J, Tan K, Poon TCW, Shim JS. PTEN deficiency confers colorectal cancer cell resistance to dual inhibitors of FLT3 and aurora kinase A. Cancer Lett 2018; 436:28-37.
• Sha M, Mao G, Wang G, Chen Y, Wu X, Wang Z. DZNep inhibits the proliferation of colon cancer HCT116 cells by inducing senescence and apoptosis. Acta Pharm Sin B 2015; 5:188-93.
• Huang F, Wang BR, Wang YG. Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma. World J Gastroenterol 2018; 24:4643-51.
• Yun CW, Lee SH. The Roles of Autophagy in cancer. Int J Mol Sci 2018; 19:E3466.
• Nazarko VY, Zhong Q. ULK1 targets Beclin-1 in autophagy. Nat Cell Biol 2013; 15:727-28.
• Miranda TB, Cortez CC, Yoo CB, Liang G, Abe M, Kelly TK, Marquez VE, Jones PA. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol Cancer Ther 2009; 8:1579-88.
• Yao Y, Hu H, Yang Y, Zhou G, Shang Z, Yang X, Sun K, Zhan S, Yu Z, Li P, Pan G, Sun L, Zhu X, He S. Downregulation of Enhancer of Zeste Homolog 2 (EZH2) is essential for the Induction of Autophagy and Apoptosis in Colorectal Cancer Cells. Genes (Basel) 2016; 7(10): E83.